Clinical Trial Update: Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of combining cetuximab with the FOLFOX4 regimen in colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• FOLFOX4 (Folinic acid (Leucovorin), Fluorouracil (5-FU), Oxaliplatin)

Snippet

Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED